Literature DB >> 18635614

MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study.

R K Fulbright1, C Hoffmann, H Lee, A Pozamantir, J Chapman, I Prohovnik.   

Abstract

BACKGROUND AND
PURPOSE: The E200K mutation of the PRNP (prion protein) gene is the most common cause of familial Creutzfeldt-Jakob disease (fCJD), which has imaging and clinical features that are similar to the sporadic form. The purpose of this study was to conduct a controlled and blinded evaluation of the sensitivity and specificity of MR imaging in this unique population.
MATERIALS AND METHODS: We compared the MR imaging characteristics of 15 early stage familial CJD patients (age, 60 +/- 7 years) with a group of 22 healthy subjects from the same families (age, 61 +/- 8 years). MR imaging included diffusion-weighted imaging (DWI), T2-weighted fast spin-echo imaging, and a fluid-attenuated inversion recovery (FLAIR) sequence. The scans were rated for abnormalities by an experienced neuroradiologist blind to diagnosis, group assignment, age, and sex.
RESULTS: Thirteen of 15 fCJD subjects had abnormal MR imaging. FLAIR signal intensity abnormality in the caudate or putamen nuclei demonstrated a sensitivity of 87% and specificity of 91%. DWI abnormality in the caudate nucleus showed a sensitivity of 73% and a specificity of 100%. Abnormalities in the thalamus (6 patients), cingulate gyrus (6 patients), frontal lobes (4 patients), and occipital lobes (3 patients) were best detected with DWI. No signal intensity abnormalities were demonstrated in the cerebellum. T2-weighted and T1-weighted sequences were uninformative.
CONCLUSIONS: FLAIR and DWI abnormalities in the caudate nucleus and putamen offer the best sensitivity and specificity for diagnosing fCJD. Our findings support recent recommendations that MR imaging should be added to the diagnostic evaluation of CJD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635614      PMCID: PMC8118770          DOI: 10.3174/ajnr.A1217

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  49 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease.

Authors:  H J Tschampa; K Kallenberg; H A Kretzschmar; B Meissner; M Knauth; H Urbach; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

3.  Diffusion-weighted MRI in two cases of familial Creutzfeldt--Jakob disease.

Authors:  R Nitrini; R A Mendonça; N Huang; A LeBlanc; J A Livramento; S K Marie
Journal:  J Neurol Sci       Date:  2001-03-01       Impact factor: 3.181

4.  Creutzfeldt-jakob disease: focus among Libyan Jews in Israel.

Authors:  E Kahana; M Alter; J Braham; D Sofer
Journal:  Science       Date:  1974-01-11       Impact factor: 47.728

5.  Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease.

Authors:  K Hsiao; Z Meiner; E Kahana; C Cass; I Kahana; D Avrahami; G Scarlato; O Abramsky; S B Prusiner; R Gabizon
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

6.  Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease.

Authors:  M M Bahn; P Parchi
Journal:  Arch Neurol       Date:  1999-05

7.  Diffusion-weighted MRI in familial Creutzfeldt-Jakob disease with the codon 200 mutation in the prion protein gene.

Authors:  Yoshio Tsuboi; Yasuhiko Baba; Katsumi Doh-ura; Akiko Imamura; Shinsuke Fujioka; Tatsuo Yamada
Journal:  J Neurol Sci       Date:  2005-05-15       Impact factor: 3.181

Review 8.  Radiological assessment of Creutzfeldt-Jakob disease.

Authors:  Henriette J Tschampa; Inga Zerr; Horst Urbach
Journal:  Eur Radiol       Date:  2006-11-09       Impact factor: 5.315

9.  Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.

Authors:  I Samman; W J Schulz-Schaeffer; J C Wöhrle; A Sommer; H A Kretzschmar; M Hennerici
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-11       Impact factor: 10.154

10.  MRI of Creutzfeldt-Jakob disease: asymmetric high signal intensity of the basal ganglia.

Authors:  S S Yoon; S Chan; S Chin; K Lee; R R Goodman
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

View more
  18 in total

1.  An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene.

Authors:  Carlo Masullo; Alessandra Bizzarro; Valeria Guglielmi; Elisabetta Iannaccone; Giacomo Minicuci; Maria Gabriella Vita; Sabina Capellari; Piero Parchi; Serenella Servidei
Journal:  Neurol Sci       Date:  2010-08-21       Impact factor: 3.307

2.  The EEG in E200K familial CJD: relation to MRI patterns.

Authors:  Shmuel A Appel; Joab Chapman; Isak Prohovnik; Chen Hoffman; Oren S Cohen; Ilan Blatt
Journal:  J Neurol       Date:  2011-08-12       Impact factor: 4.849

3.  Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology.

Authors:  Oren S Cohen; Joab Chapman; Hedok Lee; Zeev Nitsan; Shmuel Appel; Chen Hoffman; Hanna Rosenmann; Amos D Korczyn; Isak Prohovnik
Journal:  J Neurol       Date:  2010-08-21       Impact factor: 4.849

4.  Clinical findings and diagnosis in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Uta Heinemann; Claudia Ponto; Jasmine Kortt; Kai Kallenberg; Daniela Varges; Walter J Schulz-Schaeffer; Hans A Kretzschmar; Inga Zerr
Journal:  Eur J Epidemiol       Date:  2015-06-16       Impact factor: 8.082

5.  Diagnostic value of diffusion-weighted brain magnetic resonance imaging in patients with sporadic Creutzfeldt-Jakob disease: a systematic review and meta-analysis.

Authors:  Ho Young Park; Minjae Kim; Chong Hyun Suh; Sang Yeong Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-05-12       Impact factor: 5.315

6.  Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases.

Authors:  Damien Galanaud; S Haik; M G Linguraru; J-P Ranjeva; B Faucheux; E Kaphan; N Ayache; J Chiras; P Cozzone; D Dormont; J-P Brandel
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-29       Impact factor: 3.825

7.  Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases.

Authors:  Mee-Ohk Kim; Ignazio Cali; Abby Oehler; Jamie C Fong; Katherine Wong; Tricia See; Jonathan S Katz; Pierluigi Gambetti; Brianne M Bettcher; Stephen J Dearmond; Michael D Geschwind
Journal:  Acta Neuropathol Commun       Date:  2013-12-12       Impact factor: 7.801

8.  Characterization of sleep disorders in patients with E200K familial Creutzfeldt-Jakob disease.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Naama Warman-Alaluf; Yael Orlev; Gili Givaty; Zeev Nitsan; Shmuel Appel; Hanna Rosenmann; Esther Kahana; Dalia Shechter-Amir
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

9.  Clinical radiological correlation in E200K familial Creutzfeldt-Jakob disease.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Oliver L Siaw; Naama Warman-Alaluf; Zeev Nitsan; Shmuel Appel; Esther Kahana; Hanna Rosenmann; Chen Hoffmann
Journal:  J Neural Transm (Vienna)       Date:  2016-09-13       Impact factor: 3.575

Review 10.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.